Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection

Conditions:   Hepatitis C;   Hepatitis C, Chronic;   Chronic Hepatitis C;   Hepatitis C Virus Infection;   HCV Infection Interventions:   Drug: AT-527;   Drug: Daclatasvir Sponsor:   Atea Pharmaceuticals, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials